Table 5 Antimicrobial resistance profiles among the five specific molecular types of MRSA isolates.
ST239-MRSA-III-t030 (HA, n = 36) | ST5-MRSA-II-t002 (HA, n = 12) | ST239-MRSA-III-t037 (HA, n = 14) | ST59-MRSA-IVa-t437 (HA, n = 8) | ST59-MRSA-IVa-t437 (CA, n = 23) | |
|---|---|---|---|---|---|
Penicillin (%) | 100 | 100 | 100 | 100 | 100 |
Oxacillin (%) | 100 | 100 | 100 | 100 | 100 |
Erythromycin (%) | 72.2 | 58.3 | 78.6 | 100 | 82.6 |
Ciprofloxacin (%) | 94.4 | 41.7 | 78.6 | 0 | 0 |
Tetracycline (%) | 94.4 | 58.3 | 71.4 | 12.5 | 13.0 |
Clindamycin (%) | 91.7 | 91.7 | 64.3 | 25 | 78.3 |
TMP/SMX (%) | 41.7 | 33.3 | 64.3 | 25 | 0 |
Rifampicin (%) | 22.2 | 16.7 | 7.1 | 0 | 0 |
Gentamicin (%) | 94.4 | 66.7 | 50 | 25 | 0 |
Nitrofurantoin (%) | 8.3 | 0 | 21.4 | 0 | 0 |
Vancomycin (%) | 0 | 0 | 0 | 0 | 0 |
Levofloxacin (%) | 52.8 | 41.7 | 85.7 | 0.0 | 21.7 |
Linezolid (%) | 0 | 0 | 0 | 0 | 0 |
Tigecycline (%) | 0 | 0 | 0 | 0 | 0 |
Quinupristin/ Dalfopristin (%) | 0 | 0 | 0 | 0 | 0 |
